AI assistant
SCI Interim / Quarterly Report 2016
52383_rns_2016-04-12_74f52222-b95c-4485-8801-f7e406c25a61.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
員工數Employee:226 設立日期:中華民國七十六年九月十八日 Date of establishment: Sep. 18, 1987 資本額Capital:新台幣763佰萬元(NTD 763mn) 營業項目Business: 原料藥API(54.50%) 中間體Intermediate(39.96%) 特用化學品 Custom-made chemicals(5.54%)
公司概況Outline
| Y2015 | Y2016 Q1 | |||
|---|---|---|---|---|
| 歐 洲Europe |
37.07% | 39.95% | ||
| 美 洲America |
28.81% | 38.89% | ||
| 亞 洲Asia |
21.17% | 8.00% | ||
| 國 內Taiwan |
9.44% | 9.08% | ||
| 他 others 其 |
3.51% | 4.08% | ||
| 計Total 合 |
100.00% | 100.00% |
Unit: K NTD
| 2015Y | 2016 Jan to Feb | |
|---|---|---|
| 營收Sales | 1,810,501 | 388,437 |
| 營業成本COGS | (1,155,449) | (224,769) |
| 毛利Gross Profit | 655,052 | 163,668 |
| 毛利率 GP Ratio | 36.2% | 42.1% |
| 營業費用Operating Expenses | (215,195) | (54,681) |
| 營業利益Operating Income | 439,857 | 108,987 |
| 營業外損益Non-Operating In/Ex | 11,633 | 4,578 |
| 稅前淨利 Net Profit before Tax | 451,490 | 113,565 |
產品組合-Products
| Y2013 | % | Y2014 | % | Y2015 | % |
|---|---|---|---|---|---|
| PGA | 18.31% | PGA | 17.49% | HOCLQ | 21.52% |
| Di-VANa | 16.92% | Di-VANa | 10.09% | PGA | 17.14% |
| S20/38 | 8.39% | LPF.Na | 8.74% | V.A. | 10.64% |
| V.A. | 8.23% | S20/38 | 8.25% | LPF.Na | 7.48% |
| LPF.Na | 6.58% | V.A. | 8.15% | Di-VaNa | 5.41% |
| PPON | 6.53% | DBS | 4.60% | S20/38 | 4.01% |
| 5-HMT | 4.51% | 5-HMT | 4.12% | 5-HMT | 3.08% |
| PEB.Na | 3.98% | NaVA | 3.65% | DBS | 2.98% |
| NaVa | 3.34% | Pent-2 | 3.64% | Pent-2 | 2.68% |
| DBS | 2.63% | M115 | 3.33% | Dulox | 2.61% |
| Total | 79.42% | Total | 72.06% | Total | 77.55% |
| Product | % | Q1 Sales (NT\$) |
|---|---|---|
| HOCLQ | 36.84 | 237,818,831 |
| PGA | 19.06 | 123,005,850 |
| Pent-2 | 4.78 | 30,867,034 |
| Di-VANa | 3.87 | 24,989,712 |
| 5-wing | 3.56 | 22,969,387 |
| Brinzolamide | 3.52 | 22,745,214 |
| PROP-3 | 3.48 | 22,494,604 |
| PEB.Na | 2.83 | 18,262,807 |
| AL-1 | 2.64 | 17,038,857 |
| S-MMAA | 2.44 | 15,772,572 |
Hydroxychloroquine sulfate
風濕性關節炎藥物 For rheumatoid arthritis treatment
Unit : K NT\$
Pyrogallolaldehyde ( PGA) - Benserazide
Unit : K NT\$
Valproic Acid (VA)
Unit : K NT\$
治療癲癇藥物 For epilepsy treatment
產品介紹Product
Divalproex Sodium (Di-Va)
Unit : K NT\$
學名藥於2009推出 Generic came out in 2009
產品介紹Product
Loxoprofen sodium Unit : K NT\$
抗發炎藥物 Anti-inflammatory 日本市場200-300公噸 Japan market:200-300MT 2015: 25T(噸)
S20/38
臨床藥物 Medication in clinical trial
愛滋病藥物中間體 For AIDS treatment
Intermediates for Ritonavir and Lopinavir
5-Wing
產品介紹Product
Pentobarbital Sodium (鎮定安眠用, calmative)
Unit : K NT\$
Pent-2
Duloxetine(抗憂鬱症藥物, Antidepressant) 2013年底專利到期 Patent expired in the end of 2013
Unit : K NT\$
S-MMAA
GMP Status(GMP現況)
| API | CGMP Certified (TFDA) |
CEP (EDQM) |
DMF (USA) |
MF (Japan) |
DMF (Canada) |
|---|---|---|---|---|---|
| Valproic Acid (*) (#) | 2003 | 2004 | 2003 | 2008 | 2008 |
| Allopurinol | 2004 | 2003 | 2011 | ||
| Sodium Valproate |
2004 | 2006 | |||
| Divalproex Sodium (**)(#) |
2005 | 2005 | 2010 | ||
| Bisoprolol Fumarate |
2006 | ||||
| Pentobarbital Sodium |
2009 | 2 011 |
|||
| Propafenone Hydrochloride |
2010 | 2012 | 2010 | 2012 | 2012 |
| Methylphenidate HCl |
2 011 |
2014 | |||
| Duloxetine Hydrochloride |
2012 | 2014 | 2010/2011 | ||
| Thiopental | 2012 | ||||
| Loxoprofen Sodium Hydrate |
2012 | 2011 | |||
| Articaine Hydrochloride |
2013 | 2014 | 2014 | ||
| Hydroxychloroquine Sulfate(#) |
2014 | 2014 | 2014 | ||
| Clindamycin Palmitate HCl |
2011 | ||||
| Cyclophosphamide | 2014 | 2012 | |||
| Brinzolamide | 2015 | 2015 | |||
| Probucol | 2015 | 2004 |
(*)(**) FDA inspection: Nov. 2005 / April 2012, (*) EDQM inspection: Nov. 2010, (#) FDA inspection: Dec. 2014.
